Individualizing Therapy for Neovascular Age-Related Macular Degeneration with Aflibercept (VITAL): A Two-Year Prospective, Interventional Single-Centre Trial

AIMS: To report the mean change in Early Treatment Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (BCVA) and reading performance (reading acuity and maximum reading speed (MRS) using the MNREAD test) between baseline and 24 months in treatment-naïve patients with neovascular age-rel...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Praveen J., Jayaram, Hari, Eleftheriadou, Maria, Vazquez-Alfageme, Clara, Islam, Niaz, Rubin, Gary S., Pal, Bishwanath, Addison, Peter K., Hamilton, Robin, Degli Esposti, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406599/
https://www.ncbi.nlm.nih.gov/pubmed/32557168
http://dx.doi.org/10.1007/s40123-020-00267-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406599/
https://www.ncbi.nlm.nih.gov/pubmed/32557168
http://dx.doi.org/10.1007/s40123-020-00267-5

Ejemplares similares